KLK3 and neoplasm: Furthermore, by adding the stromal subtype information to the CAPRA-S risk groups we saw increased prognostic ability (Fig. 5), highlighting the possible utilization of integrating stromal information for patients where tumor-centric information (such as Gleason grading, T-stage, and serum PSA level) is inadequate to provide a clear outcome prediction.